Study for AZD4360 in Participants With Advanced Solid Tumours
Status:
RECRUITING
Trial end date:
2027-12-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, PK, immunogenicity, pharmacodynamics, and preliminary efficacy of AZD4360 in adult participants with locally advanced or metastatic solid tumours selected for expression of CLDN18.2.